ZA987392B - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number: ZA987392B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1997-08-19

Application number

ZA9807392A

Other languages

English (en)

Inventor

Allan Frank Parr

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-19

Filing date

1998-08-17

Publication date

2000-02-17

1998-08-17 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2000-02-17 Publication of ZA987392B publication Critical patent/ZA987392B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA9807392A 1997-08-19 1998-08-17 Pharmaceutical composition. ZA987392B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9717428.8A GB9717428D0 (en)	1997-08-19	1997-08-19	Pharmaceutical composition

Publications (1)

Publication Number	Publication Date
ZA987392B true ZA987392B (en)	2000-02-17

Family

ID=10817619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9807392A ZA987392B (en)	1997-08-19	1998-08-17	Pharmaceutical composition.

Country Status (15)

Country	Link
EP (1)	EP1007010A2 (xx)
JP (1)	JP2002511101A (xx)
KR (1)	KR20010014080A (xx)
CN (1)	CN1263461A (xx)
AR (1)	AR016629A1 (xx)
AU (1)	AU9343098A (xx)
BR (1)	BR9810458A (xx)
CA (1)	CA2295016A1 (xx)
CO (1)	CO4960657A1 (xx)
GB (1)	GB9717428D0 (xx)
MA (1)	MA26531A1 (xx)
PE (1)	PE105699A1 (xx)
TR (1)	TR199903209T2 (xx)
WO (1)	WO1999008666A2 (xx)
ZA (1)	ZA987392B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IS6633A (is) *	2002-11-22	2004-05-23	Omega Farma Ehf.	Samsetningar af fínasteríð töflum
WO2005016312A1 (en)	2003-08-13	2005-02-24	Nobex Corporation	Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
EP1704162A1 (de) *	2004-01-02	2006-09-27	PharmaCon Forschung und Beratung GmbH	Verfahren zur herstellung von 1,2-ungesätigten azasteroiden
WO2006055659A2 (en) *	2004-11-15	2006-05-26	Smithkline Beecham Corporation	Fixed dose combination op dutasteride and tamsulosin
WO2010117873A2 (en)	2009-04-06	2010-10-14	Banner Pharmacaps, Inc.	Progesterone solutions for increased bioavailability
ES2385240B1 (es)	2010-07-26	2013-09-23	Gp-Pharm, S.A.	Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US8900631B2 (en)	2011-04-28	2014-12-02	Health Science Funding, LLC	Dosage form to increase prasterone bioavailability
CN103169712B (zh) *	2011-12-20	2017-10-27	重庆华邦制药有限公司	提高生物利用度的度他雄胺制剂及其制备方法
WO2014002015A1 (en)	2012-06-25	2014-01-03	Ranbaxy Laboratories Limited	Pharmaceutical composition comprising dutasteride
EP2949319A1 (en)	2014-05-26	2015-12-02	Galenicum Health S.L.	Pharmaceutical compositions comprising an active agent
KR101679992B1 (ko)	2015-12-31	2016-11-28	주식회사 유유제약	프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5571817A (en) *	1984-02-27	1996-11-05	Merck & Co., Inc.	Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
DE3607651A1 (de) *	1986-03-06	1987-09-10	Schering Ag	Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer
TW408127B (en) *	1993-09-17	2000-10-11	Glaxo Inc	Androstenones
TW369521B (en) *	1993-09-17	1999-09-11	Smithkline Beecham Corp	Androstenone derivative
US5550134A (en) *	1995-05-10	1996-08-27	Eli Lilly And Company	Methods for inhibiting bone loss

1997
- 1997-08-19 GB GBGB9717428.8A patent/GB9717428D0/en active Pending
1998
- 1998-08-12 MA MA25211A patent/MA26531A1/fr unknown
- 1998-08-14 PE PE1998000735A patent/PE105699A1/es not_active Application Discontinuation
- 1998-08-14 AR ARP980104050A patent/AR016629A1/es unknown
- 1998-08-17 CA CA002295016A patent/CA2295016A1/en not_active Abandoned
- 1998-08-17 BR BR9810458-6A patent/BR9810458A/pt not_active Application Discontinuation
- 1998-08-17 ZA ZA9807392A patent/ZA987392B/xx unknown
- 1998-08-17 CN CN98806380A patent/CN1263461A/zh active Pending
- 1998-08-17 WO PCT/EP1998/005194 patent/WO1999008666A2/en not_active Ceased
- 1998-08-17 AU AU93430/98A patent/AU9343098A/en not_active Abandoned
- 1998-08-17 TR TR1999/03209T patent/TR199903209T2/xx unknown
- 1998-08-17 KR KR19997012116A patent/KR20010014080A/ko not_active Withdrawn
- 1998-08-17 JP JP51280899A patent/JP2002511101A/ja active Pending
- 1998-08-17 EP EP98946351A patent/EP1007010A2/en not_active Withdrawn
- 1998-08-18 CO CO98047010A patent/CO4960657A1/es unknown

Also Published As

Publication number	Publication date
AU9343098A (en)	1999-03-08
MA26531A1 (fr)	2004-12-20
TR199903209T2 (xx)	2000-05-22
GB9717428D0 (en)	1997-10-22
WO1999008666A2 (en)	1999-02-25
JP2002511101A (ja)	2002-04-09
CO4960657A1 (es)	2000-09-25
EP1007010A2 (en)	2000-06-14
CN1263461A (zh)	2000-08-16
WO1999008666A3 (en)	1999-04-15
KR20010014080A (ko)	2001-02-26
BR9810458A (pt)	2000-09-05
AR016629A1 (es)	2001-07-25
PE105699A1 (es)	1999-11-25
CA2295016A1 (en)	1999-02-25

Publication	Publication Date	Title
ZA9710927B (en)	1998-06-15	Pharmaceutical composition.
ZA9710071B (en)	1998-05-25	Pharmaceutical composition.
ZA965190B (en)	1997-12-19	Pharmaceutical composition.
ZA982253B (en)	1999-09-17	Therapeutic compositions.
ZA9711508B (en)	1998-06-24	Rapidly disintegrable pharmaceutical composition.
ZA974735B (en)	1997-12-01	Pharmaceutical compositions.
GB9706089D0 (en)	1997-05-14	Pharmaceutical composition
ZA981029B (en)	1999-08-10	Pharmaceutical agents.
ZA9811504B (en)	2000-06-15	Novel pharmaceutical.
ZA200005510B (en)	2001-05-08	Pharmaceutical composition.
ZA9811506B (en)	2000-11-06	Novel pharmaceutical.
ZA977104B (en)	1998-02-18	Pharmaceutical compositions.
ZA9710272B (en)	1998-06-10	Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
ZA989680B (en)	1999-07-23	Pharmaceutical composition.
ZA9811505B (en)	2000-11-06	Novel pharmaceutical.
ZA968081B (en)	1998-03-26	Pharmaceutical composition.
GB9717444D0 (en)	1997-10-22	Pharmaceutical composition
HUP0002455A3 (en)	2001-01-29	Gastric-retained pharmaceutical composition
ZA987392B (en)	2000-02-17	Pharmaceutical composition.
ZA9811502B (en)	2000-06-15	Novel composition.
CY2569B1 (en)	2008-07-02	Pharmaceutical compositions
HUP0004669A3 (en)	2005-03-29	Pharmaceutical compositions
ZA972602B (en)	1997-09-29	Pharmaceutical compositions.
IL122920A (en)	2009-09-01	Castrointestinal drug composition
ZA99890B (en)	2000-08-04	Pharmaceutical compositions.